To evaluate the ability of BZA to induce WT and mutant ERα degradation in breast cancer cells, we treated MCF-7 cells that ectopically expressed HA-tagged WT, Y537S and D538G ERα with BZA and other ligands for comparison. The gene discussed is ESR1; the disease is breast carcinoma.